Trabectedin for the treatment of relapsed ovarian cancer
| Status: |
History |
| Expected date of issue: |
TBC |
| Referral date: |
November 2008 |
| Wave: |
19 |
| Process: |
STA |
| Notes:
Since issuing the FAD, the manufacturer have requested to make a submission including a patient access scheme. This scheme has been approved by the Department of Health and in recognition of the exceptional circumstances, NICE has agreed that the appraisal can be referred back to the Appraisal Committee. The appeal stage of this appraisal topic has been suspended. This will allow for the Appraisal Committee to consider the new evidence submitted.
|
Topic area:
-
Cancer
-
Gynaecology, pregnancy and birth
|
NICE project team
| Executive Lead: |
Gillian Leng
|
| Technical Lead: |
Sally Doss
|
| Communications manager: |
Laura Gibson
|
| Project manager: |
Bijal Joshi
|
Provisional schedule
| Closing date for invited submissions / evidence submission: |
04 February 2010 |
| 1st appraisal committee meeting: |
18 May 2010 |
| 2nd appraisal committee meeting |
22 July 2010 |
| 3rd appraisal committee meeting: |
18 January 2011 |
Consultees and commentators
|
| Consultees |
Commentators (no right to submit or appeal) |
|
Manufacturers/sponsors
Patient/carer groups
- Afiya Trust
- Black Health Agency
- CANCERactive
- Cancer Black Care
- Cancer Equality
- Chinese National Healthy Living Centre
- Confederation of Indian Organisations
- Counsel and Care
- Equalities National Council
- Gynae C
- Helen Rollason Heal Cancer Charity
- Macmillan Cancer Support
- Maggie’s Centres
- Marie Curie Cancer Care
- Muslim Council of Great Britain
- Muslim Health Network
- National Cancer Alliance
- National Council for Palliative Care
- Ovacome
- Ovarian Cancer Action
- South Asian Health Foundation
- Specialised Healthcare Alliance
- Sue Ryder Care
- Target Ovarian Cancer
- Tenovus
- Well Being of Women
- Women’s Health Concern
Professional groups
- Association of Cancer Physicians
- British Association for Services to the Elderly
- British Geriatrics Society
- British Gynaecological Cancer Society
- British Oncological Association (BOA)
- British Psychosocial Oncology Society
- Cancer Networks Pharmacists Forum
- Cancer Research UK
- Royal College of General Practitioners
- Royal College of Nursing
- Royal College of Obstetricians & Gynaecologists
- Royal College of Pathologists
- Royal College of Physicians, Medical Oncology Joint Special Committee
- Royal Pharmaceutical Society
- Royal Society of Medicine – Intellectual Disabilities Forum
- United Kingdom Clinical Pharmacy Association
- United Kingdom Oncology Nursing Society
Others
- Blackpool PCT
- Carmarthenshire LHB
- Department of Health
- Welsh Assembly Government
|
General
- Board of Community Health Councils in Wales
- British National Formulary
- Commissioning Support Appraisals Service
- Department of Health, Social Services and Public Safety for Northern Ireland
- Medicines and Healthcare products Regulatory Agency
- National Association of Primary Care
- National Public Health Service for Wales
- NHS Alliance
- NHS Confederation
- NHS Purchasing and Supply Agency
- NHS Quality Improvement Scotland
- Scottish Medicines Consortium
Comparator manufacturer(s)
- Accord Healthcare (gemcitabine)
- Actavis UK (gemcitabine, paclitaxel)
- Bristol-Myers Squibb (paclitaxel)
- Eli Lilly (gemcitabine)
- GlaxoSmithKline (topotecan)
- Hospira UK (carboplatin, cisplatin gemcitabine, paclitaxel)
- Mayne Pharma (paclitaxel)
- Medac GmbH (gemcitabine, paclitaxel)
- Pfizer (cisplatin)
- Schering-plough (pegylated liposomal doxorubicin hydrochloride)
- Stragen UK (paclitaxel)
- Sun Pharmaceuticals UK (gemcitabine)
- Teva UK (gemcitabine, paclitaxel)
- Wockhardt UK (paclitaxel)
Relevant research groups
- Eve appeal
- Institute of Cancer Research
- MRC Clinical Trials Unit
- National Cancer Research Institute
- National Cancer Research Network
- National Institute for Health Research
- Policy Research Institute on Ageing and Ethnicity
- Research Institute for the Care of Older People
Evidence Review Group
- National Institute for Health Research Health Technology Assessment Programme
- NHS Centre for Reviews & Dissemination and Centre for Health Economics -York
Associated Guideline Groups
- National Collaborating Centre for Cancer
Associated Public Health Groups
|
|
Key documents
This page was last updated: 04 May 2011
